Kiora Pharmaceuticals (KPRX) Stock Rose 62% Pre-Hours. How Did That Happen?

As a result of regulatory approval, Kiora Pharmaceuticals Inc (NASD: KPRX) has soared 62.20% at $5.32 in pre-market trading hours on Tuesday. KPRX has seen a dramatic increase in its share price, pointing towards a very successful future for the company. What does KPRX get the go-ahead for? The Phase 2 trial of KIO-101 for […]

The Baxter Report
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.